Acuña D, Aceves C, Anguiano B, Meza G
Departamento de Neurociencias, Instituto de Fisiología Celular, UNAM, Mexico.
Brain Res. 1990 Dec 17;536(1-2):133-8. doi: 10.1016/0006-8993(90)90017-6.
The vestibular cell type affected by congenital hypothyroidism (CH) was investigated by measuring the activity of glutamate decarboxylase (GAD) and choline acetyltransferase (ChAT), synthesizing enzymes of putative afferent (GABA) and efferent (acetylcholine, ACh) neurotransmitters and thus, respectively, hair cell I and II (HC-I, HC-II), and efferent terminal (ET) marker enzymes, in vestibular homogenates of control, congenitally hypothyroid rats (CHR) and in thyroxine-replaced CHR (CHR-T4) whose postnatal age ranged from 20 to 60 days old. In the vestibule, CH-II and its efferent cholinergic contacting bouton mature prior to thyroid function whereas HC-I-differentiation and its efferent synapse arrival are the latest events in vestibular maturation. Therefore, a differential effect of CH upon GAD and ChAT in CHR could be anticipated. In control rats as in CHR the magnitude of GAD was the same with time starting on the 20th day. In CHR, ChAT gradually diminished beginning on day 28 to become 45% decreased with respect to control on the 60th postnatal day. Prevention of ChAT decrease in CHR by early administration of thyroxine (T4), a striking diminution of T4 and triiodothyronine (T3) in CHR serum and a normal level of these hormones found in CHR-T4 corroborated thyroid involvement. These results confirm the preference of hypothyroidism to affect cholinergic cell types (or compartments) of late maturation (HC-I-containing ET and hence 45% ChAT decrease) leaving HC-I, HC-II and HC-II-connecting ET untouched, supported by a 55% remanent ChAT and a constant GAD activity regardless of time and treatment.
通过测量谷氨酸脱羧酶(GAD)和胆碱乙酰转移酶(ChAT)的活性,对受先天性甲状腺功能减退症(CH)影响的前庭细胞类型进行了研究。这两种酶分别是假定的传入神经递质(γ-氨基丁酸,GABA)和传出神经递质(乙酰胆碱,ACh)的合成酶,因此分别是毛细胞I和II(HC-I、HC-II)以及传出终末(ET)的标志物酶。研究对象包括对照组、先天性甲状腺功能减退大鼠(CHR)以及出生后20至60日龄的甲状腺素替代CHR(CHR-T4)的前庭匀浆。在前庭中,HC-II及其传出胆碱能接触终扣在甲状腺功能之前就已成熟,而HC-I的分化及其传出突触的形成是前庭成熟过程中最晚发生的事件。因此,可以预期CH对CHR中GAD和ChAT会有不同的影响。在对照组大鼠和CHR中,从第20天开始,GAD的活性随时间变化保持相同。在CHR中,ChAT从第28天开始逐渐减少,到出生后第60天相对于对照组降低了45%。早期给予甲状腺素(T4)可防止CHR中ChAT减少,CHR血清中T4和三碘甲状腺原氨酸(T3)显著减少,而在CHR-T4中这些激素水平正常,这证实了甲状腺的参与。这些结果证实,甲状腺功能减退症倾向于影响成熟较晚的胆碱能细胞类型(或部分)(含HC-I的ET,因此ChAT减少45%),而HC-I、HC-II以及连接HC-II的ET不受影响,这一点得到了55%的残留ChAT和无论时间及治疗如何均保持恒定的GAD活性的支持。